The sports category has moved to a new website.

MoH recalls paracetamol solution from shelves: What you need to know

Here is why the Ministry of Health has recalled the popular painkiller, Paracetamol oral solution

Paracetamol oral solution.

The Ministry of Health through the Pharmacy and Poisons Board (PPB), has issued a recall notice for the Tamedol oral solution (Paracetamol oral solution, 120mg/5m1, 60 mls) due to concerns about its quality.

This decision follows complaints received regarding the drug's effectiveness and safety.

In an official statement released on Tuesday, the PPB declared that the Tamedol oral solution, manufactured by Biopharma LTD, did not meet the stipulated market authorization requirements.

ADVERTISEMENT

As a result, the board has advised all pharmaceutical outlets, healthcare facilities, healthcare professionals, and the general public to take immediate action in halting the distribution and consumption of this particular drug.

"STOP all further distribution, sale, issuing, or use of Tamedol oral solution. Members of the public are urged to return the product to their nearest healthcare facility, while healthcare facilities are instructed to return the products to their respective suppliers," read part of the statement.

In addition to the Tamedol oral solution, the PPB also raised concerns about the sale of Visipaque (Iodixanol) 320 mg/mL vial following reports of quality defects and suspected adverse events.

ADVERTISEMENT

The preliminary investigations conducted by the board revealed that these affected product batches had entered the market through unauthorized and illegal supply chains, raising serious safety concerns

"In light of these concerns, the PPB initiated preliminary investigations, which revealed that the affected product batches had infiltrated the market illegally, having been imported and distributed through unauthorized and illegal supply chains," read the statement.

PPB promptly urged healthcare facilities possessing the affected product batches to quarantine them and report to the board's offices for further guidance and necessary action.

The identified batches of Visipaque (Iodixanol) 320 mg/mL were manufactured by GE Healthcare Ireland and GE Healthcare (Shanghai) Co., Ltd, with specific batch numbers listed.

JOIN OUR PULSE COMMUNITY!

Unblock notifications in browser settings.
ADVERTISEMENT

Eyewitness? Submit your stories now via social or:

Email: news@pulselive.co.ke

Recommended articles

Celebrities & government employees who made remarkable career comebacks in 2024

Celebrities & government employees who made remarkable career comebacks in 2024

Understanding the process of grief & tips to cope with loss of a loved one

Understanding the process of grief & tips to cope with loss of a loved one

Daniel Koikai’s final moments before death struck on daughter Jahmbi Koikai’s burial day

Daniel Koikai’s final moments before death struck on daughter Jahmbi Koikai’s burial day

9 things you should never say to your step-children

9 things you should never say to your step-children

9 ideas to improve your remote working experience

9 ideas to improve your remote working experience

If your wife has these 15 behaviours, she's cheating with a Range Rover owner

If your wife has these 15 behaviours, she's cheating with a Range Rover owner

What typical African American weddings look like

What typical African American weddings look like

How to use Mukombero properly to achieve maximum benefits

How to use Mukombero properly to achieve maximum benefits

Ladies: Drop these 7 outfits from your wardrobe to attract high-value men

Ladies: Drop these 7 outfits from your wardrobe to attract high-value men

ADVERTISEMENT